Cell‑based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report

  • Authors:
    • Ranganathan Chidambaram
    • Hiroshi Terunuma
    • Madasamy Balamurugan
    • Vidyasagar Devaprasad Dedeepiya
    • Premkumar Sumana
    • Rajappa Senthilkumar
    • Mathaiyan Rajmohan
    • Ramalingam Karthick
    • Senthilkumar Preethy
    • Samuel J.K. Abraham
  • View Affiliations

  • Published online on: July 19, 2017     https://doi.org/10.3892/mco.2017.1333
  • Pages: 493-497
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cancer stem cells in breast cancer migrating to the bone marrow may cause future metastasis, particularly during periods of decreased immunity. Natural killer (NK) cells have a role in immune surveillance and are able to target cancer stem cells. The present study reported a case in which NK cell‑based autologous immune enhancement therapy was used combined with conventional treatments in a patient with stage IIIA breast cancer, yielding >28 months of disease‑free survival. However, there was a gradual decline in the in vitro expansion of NK cells with subsequent chemotherapeutic treatments. As this NK cell decline following chemotherapy may contribute to cancer cell immune evasion and future metastasis; modifying current cancer therapies in order to avoid potentially compromising the immune system may lead to improved treatment outcomes.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 7 Issue 3

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chidambaram R, Terunuma H, Balamurugan M, Dedeepiya VD, Sumana P, Senthilkumar R, Rajmohan M, Karthick R, Preethy S, Abraham SJ, Abraham SJ, et al: Cell‑based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report. Mol Clin Oncol 7: 493-497, 2017.
APA
Chidambaram, R., Terunuma, H., Balamurugan, M., Dedeepiya, V.D., Sumana, P., Senthilkumar, R. ... Abraham, S.J. (2017). Cell‑based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report. Molecular and Clinical Oncology, 7, 493-497. https://doi.org/10.3892/mco.2017.1333
MLA
Chidambaram, R., Terunuma, H., Balamurugan, M., Dedeepiya, V. D., Sumana, P., Senthilkumar, R., Rajmohan, M., Karthick, R., Preethy, S., Abraham, S. J."Cell‑based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report". Molecular and Clinical Oncology 7.3 (2017): 493-497.
Chicago
Chidambaram, R., Terunuma, H., Balamurugan, M., Dedeepiya, V. D., Sumana, P., Senthilkumar, R., Rajmohan, M., Karthick, R., Preethy, S., Abraham, S. J."Cell‑based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report". Molecular and Clinical Oncology 7, no. 3 (2017): 493-497. https://doi.org/10.3892/mco.2017.1333